Scarica l'app Stockscreener
45.09
4.13%
1.79
Dopo l'orario di chiusura:
45.09
Sionna Therapeutics Inc Borsa (SION) Ultime notizie
Sionna Therapeutics stock hits all-time high at 45.17 USD By Investing.com - Investing.com India
Sionna Therapeutics stock hits all-time high at 45.17 USD - Investing.com
SION Options Volatility — NASDAQ:SION - TradingView — Track All Markets
Aug Technicals: How Sionna Therapeutics Inc. stock reacts to global recession fearsDividend Hike & Fast Moving Stock Trade Plans - bollywoodhelpline.com
SION Options Chain — NASDAQ:SION - TradingView — Track All Markets
Is Sionna Therapeutics Inc undervalued by DCF analysisPortfolio Update Report & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Growth Value: Whats the MACD signal for Sionna Therapeutics Inc2026 Summary & Expert-Curated Trade Recommendations - baoquankhu1.vn
Gains Recap: Whats the outlook for Sionna Therapeutics Incs sector2026 Analyst Calls & Expert-Curated Trade Recommendations - baoquankhu1.vn
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium - Bitget
Sionna Therapeutics (NASDAQ:SION) Stock Price Down 4.4%Here's What Happened - MarketBeat
Dip Buying: Is Sionna Therapeutics Inc stock a buy or sell2026 Earnings & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Aberdeen Group plc Sells 110,587 Shares of Sionna Therapeutics, Inc. $SION - marketbeat.com
Sionna Therapeutics, Inc.Common Stock (NQ: SION - The Chronicle-Journal
OrbiMed Advisors LLC sells Sionna Therapeutics (SION) stock worth $1.37m - Investing.com
Sionna Therapeutics Executive Sells Shares - Intellectia AI
Sionna Therapeutics CLO Divests All Direct Stock Holdings in March 2026News and Statistics - IndexBox
Sionna Therapeutics (NASDAQ:SION) Trading 8.8% HigherTime to Buy? - MarketBeat
Sionna Chief Legal Officer Cashed Out Her Shares. Her Options Are Another Story - Yahoo Finance
Sionna Chief Legal Officer Cashed Out Her Shares. Her Options Are Another Story - The Motley Fool
Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? - aol.com
Aug PreEarnings: Should you avoid Sionna Therapeutics Inc stock right now2026 Catalysts & High Conviction Buy Zone Picks - baoquankhu1.vn
SION Forecast, Price Target & Analyst Ratings | SIONNA THERAPEUTICS INC (NASDAQ:SION) - ChartMill
Setup Watch: Is Sionna Therapeutics Inc currently under institutional pressureTrade Analysis Summary & Verified Swing Trading Watchlists - baoquankhu1.vn
SION Technical Analysis | Trend, Signals & Chart Patterns | SIONNA THERAPEUTICS INC (NASDAQ:SION) - ChartMill
Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Shares Up 3.8%Here's What Happened - MarketBeat
JPMorgan Chase & Co. Lowers Stake in Sionna Therapeutics, Inc. $SION - MarketBeat
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares - AOL.com
Superstring Capital Invests in Sionna Therapeutics: Q4 2025 Filing DetailsNews and Statistics - IndexBox
'This is one of your classic, binary biotech stocks': Baral on Sionna Therapeutics - BNN Bloomberg
This investor offloaded $5 million worth of a biotech stock that surged 118% over the past year, yet there are still reasons to believe they remain optimistic about its future performance. - Bitget
Braidwell LP Has $9.24 Million Stake in Sionna Therapeutics, Inc. $SION - MarketBeat
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Health Catalyst (HCAT) - The Globe and Mail
Sionna Therapeutics, Inc. $SION Shares Sold by Atlas Venture Life Science Advisors LLC - MarketBeat
SION: Advancing NBD1 stabilizers for cystic fibrosis with pivotal data expected by mid-2026 - TradingView
Analysts Are Bullish on These Healthcare Stocks: Sionna Therapeutics, Inc. (SION), Privia Health Group (PRVA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: GH Research (GHRS) and Sionna Therapeutics, Inc. (SION) - The Globe and Mail
Loss Report: Is now the right time to enter Sionna Therapeutics IncMarket Risk Summary & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Sionna Therapeutics chief legal officer sells shares for $347,018 By Investing.com - Investing.com Australia
Sionna Therapeutics chief legal officer sells shares for $347,018 - Investing.com
TD Asset Management Inc Grows Position in Sionna Therapeutics, Inc. $SION - MarketBeat
[144] Sionna Therapeutics, Inc. SEC Filing - Stock Titan
Reassessing Sionna Therapeutics (SION) Valuation After Recent Share Price Pullback And CF Pipeline Progress - simplywall.st
UBS Maintains Buy on Sionna Therapeutics, Inc. (SION) March 02, 2026 - Meyka
SION: NBD1 stabilization could transform CF care, with dual and add-on therapies advancing in clinical trials - TradingView
Sionna Therapeutics (NASDAQ:SION) Earns Buy Rating from BTIG Research - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Shares Gap DownShould You Sell? - MarketBeat
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):